Actively Recruiting
Study Evaluating the Progression and Screening of Alcohol-Related Liver Disease in Adults Aged 18 to 75
Led by University Hospital, Lille · Updated on 2026-05-22
7500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying alcoholic liver disease, which includes fatty liver, fibrosis, and alcoholic hepatitis AH. This condition can progress to cirrhosis, especially in patients with alcoholic hepatitis, which causes inflammation and speeds up fibrosis. The study aims to improve understanding of disease progression in heavy drinkers using non-invasive methods to detect extensive liver fibrosis and assess the risk of cirrhosis and liver complications over time. The trial observes groups of patients categorized by their risk level of liver fibrosis, including those with minimal risk, intermediate risk, high risk, compensated cirrhosis, and those experiencing their first liver decompensation event. Non-invasive tests like ultrasound elastography FibroScan, FibroTest, AshTest, and other fibrosis assessment tools are used for evaluation. Patients will be followed longitudinally for at least five years to monitor disease progression and liver health outcomes. Participants will undergo assessments including liver imaging, blood tests, and questionnaires about alcohol consumption. Researchers will track the first clinical diagnosis of cirrhosis or its complications, overall mortality, and liver disease progression. Blood and tissue samples may be collected for further study. The study also includes regular monitoring to detect liver-related events and evaluate the effectiveness of screening strategies in heavy drinkers over a five-year period.
CONDITIONS
Brief Title
Study of Alcohol-related Liver Disease in Europe
Research Team
P
Philippe Mathurin, MD,PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here